Picard Medical, Inc. has announced the appointment of Richard Fang, Ph.D., as its new Chief Executive Officer, effective October 28, 2026. This leadership change is significant for the company, as it seeks to solidify its position in the competitive surgical and medical instruments market.

Dr. Fang has been with Picard Medical since September 2021 and has served as the interim CEO since June 2026. His appointment as permanent CEO reflects the Board of Directors' confidence in his leadership abilities and vision for the company. Dr. Fang's extensive background in the medical technology field, including his previous role as CEO of Reach Surgical, positions him well to guide Picard Medical into its next phase of growth.

Background

Founded in Delaware, Picard Medical, Inc. operates under the SIC code 3841, which pertains to Surgical & Medical Instruments & Apparatus. The company is listed on the New York Stock Exchange under the ticker symbol PMI. Recent filings include an 8-K on November 3, 2026, detailing Dr. Fang's appointment and other related corporate actions.

What the Filing Says

The SEC filing states, "On October 28, 2026, the Board of Directors appointed Richard Fang, Ph.D., as the Company’s Chief Executive Officer on a permanent, full-time basis, effective as of the same date." Dr. Fang will also continue to serve as Chairman of the Board.

Dr. Fang, age 60, has a robust history in the medical device industry, having founded Hunniwell Lake Ventures LLC and previously leading Reach Surgical to significant growth before its sale to a private equity firm. His academic credentials include an MBA from the University of Cincinnati and a Ph.D. in Physics from Purdue University.

Importantly, the filing notes that Dr. Fang's annual salary remains at $0.4 million, and there were no new or amended compensation arrangements associated with his appointment.

Impact

This leadership change may affect various stakeholders, including employees, investors, and partners within the medical instruments sector. Dr. Fang's established track record and industry connections could enhance Picard Medical's strategic initiatives and operational effectiveness. Additionally, the company's focus on innovation under Dr. Fang's leadership may lead to new product developments and market opportunities.

What's Next

The filing does not say what happens next. However, the industry will likely watch closely as Dr. Fang implements his vision for Picard Medical, particularly in the context of ongoing developments in the surgical and medical instruments market.